A carregar cotações...
Previsão
O preço-alvo médio dos analistas é € 12,48 (+1.460,00%). A mediana é € 9,50 (+1.087,50%).
| Comprar |
9 |
| Manter |
11 |
| Vender |
7 |
Notícias Ir para o feed de notícias
Canopy Growth: analysts see smaller loss and revenue increase in latest quarter
Canopy Growth expects to release quarterly results for the period ended March 31, 2026, likely on June 15, 2026. Four analysts on average forecast an earnings decline to -0.102 CAD per share versus -1.430 CAD a year ago. Six analysts estimate quarterly revenue at 74.3 million CAD, up 14.27% from 65.0 million CAD in the year-ago quarter. For the fiscal year, seven analysts project total revenue of 286.0 million CAD and an average annual loss of -0.459 CAD per share versus -5.560 CAD in the prior year. » Mais em finanzen.net
Canopy Growth misses EPS guidance in Q3 2026, beats revenue forecasts
Canopy Growth reported Q3 2026 EPS of -0.18 CAD (expectation: -0.04 CAD), significantly missing the estimate, while revenue of 74.54 million CAD exceeded the expected 50.88 million CAD by 46.5%. Adjusted EBITDA loss was reduced to 3 million CAD, the strongest result to date. Management aims for positive adjusted EBITDA by fiscal 2027, relying on operational efficiency, cost discipline and the acquisition of MTL Cannabis to improve margins. The stock moved only slightly premarket, trading around 1.08 CAD. » Mais em de.investing.com
Dados financeiros da empresa
| (EUR) | junho de 2026 | |
|---|---|---|
| Receitas | 50,06 mi | 11,28% |
| Ganho bruto | 13,71 mi | 21,93% |
| Ganho líquido | -8,99 mi | 65,28% |
| EBITDA | -2,88 mi | 78,82% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 349,19 mi |
Número de ações | 422,15 mi |
Máximo/mínimo de 52 semanas | € 2,05 - € 0,73 |
| Dividendos | Não |
Beta | 2,41 |
PER (PE Ratio) | -1,97 |
PEG (PEG Ratio) | -0,01 |
P/VC (PB Ratio) | 0,81 |
P/V (PS Ratio) | 0,75 |
Perfil da empresa
Die Canopy Growth Corporation ist zusammen mit ihren Tochtergesellschaften in der Produktion, dem Vertrieb und dem Verkauf von Cannabis- und Hanfprodukten für Freizeit- und medizinische Zwecke hauptsächlich in Kanada, den Vereinigten Staaten und Deutschland tätig. Das Unternehmen ist in zwei Segmenten tätig: Global Cannabis und andere Verbraucherprodukte. Zu den Produkten des Unternehmens gehören getrocknete Cannabisblüten, Extrakte und Konzentrate, Getränke, Gummibärchen und Vapes. Es bietet seine Produkte unter den Marken Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, und Truverra an. Das Unternehmen war früher als Tweed Marijuana Inc. bekannt und änderte im September 2015 seinen Namen in Canopy Growth Corporation. Canopy Growth Corporation wurde 2009 gegründet und hat seinen Hauptsitz in Smiths Falls, Kanada.
| Nome | CANOPY GROWTH |
| CEO | Luc Mongeau |
| Sede | Smiths Falls,
on Canadá |
| Site | |
| Setor | Cuidados de saúde |
| Indústria | Produtos farmacêuticos |
| Entrada em bolsa | 07/04/2014 |
| Colaboradores | 1.128 |
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NASDAQ | CGC |
Toronto Stock Exchange | WEED.TO |
Frankfurt | 11L.F |
Düsseldorf | 11L.DU |
Hamburg | 11L.HM |
München | 11L.MU |
SIX | CGC.SW |
